Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)

NCT01351675 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01351675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01351675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2011
Completion date
December 31, 2012
Enrollment
2,185 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, renal insufficiency, chronic